The Business Research Company’s report on the Gene Delivery Technologies Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the gene delivery technologies market further?
The increasing number of cell and gene therapies is expected to propel the growth of the gene delivery technologies market going forward. Cell and gene therapies refer to medical treatments that aim to cure or alleviate diseases by altering a patient’s body’s genetic and cellular makeup. The increasing number of cell and gene therapies is mainly driven by advancements in gene editing technologies, playing a critical role in developing and commercializing cell and gene therapies. For instance, in August 2024, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the UK medicines regulator has historically approved an average of two ATMPs annually, but this figure is expected to rise to 10–15 approvals per year by 2030. The number of individuals treated with these therapies in the UK could increase from 2,500 in 2021 to as many as 10,000 per year by 2028. Therefore, increasing cell and gene therapies drives the gene delivery technologies market.
Access Your Free Sample of the Global Gene Delivery Technologies Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp
What are the key factors influencing the forecasted market size of the gene delivery technologies industry?
The gene delivery technologies market size has grown rapidly in recent years. It will grow from$3.79 billion in 2024 to $4.3 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to enhanced understanding of genetic diseases, advancements in cell therapy, evolution of nanotechnology, growth of gene therapy trials, research funding increase
The gene delivery technologies market size is expected to see rapid growth in the next few years. It will grow to “$7.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to precision medicine development, regulatory framework enhancements, proliferation of gene therapy, expansion of non-viral delivery systems. Major trends in the forecast period include application in rare diseases, rise in clinical trials, targeted drug delivery, expansion of cell therapy, development of gene editing tools.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp
Who are the leading competitors in the gene delivery technologies market?
Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG
Which emerging trends are set to transform the gene delivery technologies market landscape?
Technological advancement has emerged as a key trend gaining popularity in the gene delivery technologies market. Major market players are concentrating their efforts on creating technologically advanced products to strengthen their position in the market. For instance, in February 2023, Aera Therapeutics, a US-based biotechnology company, launched Aera’s Platform delivery technology to unlock the potential of genetic medicines. Aera’s PNP technology allows for the precise targeting of RNA molecules that are involved in disease processes. This technology allows for the targeted editing of genes in a patient’s cells, offering the potential for personalized gene therapies.
How do different geographies compare in terms of market share and growth potential in the gene delivery technologies market?
North America was the largest region in the gene delivery technologies market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Which major segments of the gene delivery technologies market are experiencing the fastest growth?
The gene delivery technologies market covered in this report is segmented –
1) By Mode: Biological, Chemical, Physical
2) By Method: Ex Vivo, In Vivo, In Vitro
3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research
Subsegments:
1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles
2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents
3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10706
How is the gene delivery technologies market defined, and what are its core characteristics?
Gene delivery technologies refer to methods that are used to introduce foreign genetic material, such as DNA or RNA, into cells, where the goal of gene delivery is to transfer the genetic material into the target cells. These technologies are commonly used in treating diseases or disorders caused by changed gene-like mutations or an inherited gene.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
